Skip to main content
SpringerLink
Log in

Nonsteroidal Anti-inflammatory Drugs

  • Chapter
  • First Online:
Book cover Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most widely used analgesic medications in the world because of their ability to reduce pain and inflammation. The NSAIDs are structurally diverse, but all have antipyretic, anti-inflammatory, and analgesic properties. The salicylates (aspirin-like medications) have been used to treat pain conditions for thousands of years. Greater than 100 million prescriptions for NSAIDs are written by clinicians in the United States each year, and more than 30 million Americans use prescription or over-the-counter (OTC) NSAIDs regularly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. De Ledinghen V, Heresbach D, Fourdan O, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut. 999;44(2):270–3.

    Article  Google Scholar 

  2. Godal HC, Eika C, Dybdahl JH, et al. Aspirin and bleeding-time. Lancet. 1979;1(8128):1236.

    Article  PubMed  CAS  Google Scholar 

  3. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001;120(3):594–606.

    Article  PubMed  CAS  Google Scholar 

  4. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(3A):2S–8. discussion 21S–22S.

    Article  PubMed  CAS  Google Scholar 

  5. Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, rheumatism, and aging medical information system. Am J Ther. 2000;7(2):115–21.

    Article  PubMed  CAS  Google Scholar 

  6. Jouzeau JY, Terlain B, Abid A, et al. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs. 1997;53(4):563–82.

    Article  PubMed  CAS  Google Scholar 

  7. Talley NJ, Evans JM, Fleming KC, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995;40(6):1345–50.

    Article  PubMed  CAS  Google Scholar 

  8. Tannenbaum H, Bombardier C, Davis P, et al. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. J Rheumatol. 2006;33(1):140–57.

    PubMed  Google Scholar 

  9. Eisenberg E, Berkey CS, Carr DB, et al. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol. 1994;12(12):2756–65.

    PubMed  CAS  Google Scholar 

  10. Burke Anne SE, FitzGerald Garret A. Chapter 26: Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy of gout. In: Goodman & Gilman’s the pharmacological basis of therapeutics. 2011. [11th: http://www.accessmedicine.com/content.aspx?aID=942390]. Accessed 11 Feb 2010.

  11. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46–55.

    Article  PubMed  Google Scholar 

  12. Munsterhjelm E, Munsterhjelm NM, Niemi TT, et al. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology. 2005;103(4):712–17.

    Article  PubMed  CAS  Google Scholar 

  13. Lanza FL. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl. 1989;163:24–31.

    Article  PubMed  CAS  Google Scholar 

  14. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA. 1994;91(25):12013–17.

    Article  PubMed  CAS  Google Scholar 

  15. Gordon SM, Brahim JS, Rowan J, et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Clin Pharmacol Ther. 2002;72(2):175–83.

    Article  PubMed  CAS  Google Scholar 

  16. McCormack K. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs. 1994;47 Suppl 5:28–45; discussion 46–47.

    Article  PubMed  CAS  Google Scholar 

  17. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52 Suppl 5:13–23.

    Article  PubMed  CAS  Google Scholar 

  18. Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl. 1995;103:1–44.

    PubMed  CAS  Google Scholar 

  19. Kroin JS, Buvanendran A, McCarthy RJ, et al. Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg Anesth Pain Med. 2002;27(5):451–5.

    PubMed  CAS  Google Scholar 

  20. Vasko MR. Prostaglandin-induced neuropeptide release from spinal cord. Prog Brain Res. 1995;104:367–80.

    Article  PubMed  CAS  Google Scholar 

  21. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol. 2002;42:553–83.

    Article  PubMed  CAS  Google Scholar 

  22. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410(6827):471–5.

    Article  PubMed  CAS  Google Scholar 

  23. Samad TA, Sapirstein A, Woolf CJ. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 2002;8(8):390–6.

    Article  PubMed  CAS  Google Scholar 

  24. Brune K, Glatt M, Graf P. Mechanisms of action of anti-inflammatory drugs. Gen Pharmacol. 1976;7(1):27–33.

    Article  PubMed  CAS  Google Scholar 

  25. Davies NM, Skjodt NM. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach. Clin Pharmacokinet. 2000;38(5):377–92.

    Article  PubMed  CAS  Google Scholar 

  26. Munir MA, Enany N, Zhang JM. Nonopioid analgesics. Med Clin North Am. 2007;91(1):97–111.

    Article  PubMed  CAS  Google Scholar 

  27. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364–72.

    Article  PubMed  CAS  Google Scholar 

  28. Mann JF, Goerig M, Brune K, et al. Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol. 1993;39(1):1–6.

    PubMed  CAS  Google Scholar 

  29. Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J Paediatr Child Health. 2008;44(1–2):3–9.

    PubMed  Google Scholar 

  30. Derry C, Derry S, Moore RA, et al. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;3:CD001548.

    PubMed  Google Scholar 

  31. Grimes DA, Hubacher D, Lopez LM, et al. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006;4:CD006034.

    PubMed  Google Scholar 

  32. Olson NZ, Otero AM, Marrero I, et al. Onset of analgesia for liquigel ibuprofen 400 mg, acetaminophen 1000 mg, ketoprofen 25 mg, and placebo in the treatment of postoperative dental pain. J Clin Pharmacol. 2001;41(11):1238–47.

    Article  PubMed  CAS  Google Scholar 

  33. Barden J, Derry S, McQuay HJ, et al. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;4:CD007355.

    PubMed  Google Scholar 

  34. Moore RA, Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol. 2008;8:11.

    Article  PubMed  Google Scholar 

  35. Davies NM. Clinical pharmacokinetics of oxaprozin. Clin Pharmacokinet. 1998;35(6):425–36.

    Article  PubMed  CAS  Google Scholar 

  36. Kean WF. Oxaprozin: kinetic and dynamic profile in the treatment of pain. Curr Med Res Opin. 2004;20(8):1275–7.

    Article  PubMed  CAS  Google Scholar 

  37. Kurowski M, Thabe H. The transsynovial distribution of oxaprozin. Agents Actions. 1989;27(3–4):458–60.

    Article  PubMed  CAS  Google Scholar 

  38. Dallegri F, Bertolotto M, Ottonello L. A review of the emerging profile of the anti-inflammatory drug oxaprozin. Expert Opin Pharmacother. 2005;6(5):777–85.

    Article  PubMed  CAS  Google Scholar 

  39. Olson NZ, Sunshine A, Zighelboim I, et al. Onset and duration of analgesia of diclofenac potassium in the treatment of postepisiotomy pain. Am J Ther. 1997;4(7–8):239–46.

    Article  PubMed  CAS  Google Scholar 

  40. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet. 1997;33(3):184–213.

    Article  PubMed  CAS  Google Scholar 

  41. Derry P, Derry S, Moore RA, et al. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;2:CD004768.

    PubMed  Google Scholar 

  42. Bruhlmann P, de Vathaire F, Dreiser RL, et al. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin. 2006;22(12):2429–38.

    Article  PubMed  CAS  Google Scholar 

  43. Petersen B, Rovati S. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin Drug Investig. 2009;29(1):1–9.

    Article  PubMed  CAS  Google Scholar 

  44. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96(13):7563–8.

    Article  PubMed  CAS  Google Scholar 

  45. Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol Int. 1990;10(Suppl):9–16.

    Article  PubMed  Google Scholar 

  46. Lynch S, Brogden RN. Etodolac. A preliminary review of its pharmacodynamic activity and therapeutic use. Drugs. 1986;31(4):288–300.

    Article  PubMed  CAS  Google Scholar 

  47. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53(1):139–88.

    Article  PubMed  CAS  Google Scholar 

  48. Buckley MM, Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1990;39(1):86–109.

    Article  PubMed  CAS  Google Scholar 

  49. Morley-Forster P, Newton PT, Cook MJ. Ketorolac and indomethacin are equally efficacious for the relief of minor postoperative pain. Can J Anaesth. 1993;40(12):1126–30.

    Article  PubMed  CAS  Google Scholar 

  50. Resman-Targoff BH. Ketorolac: a parenteral nonsteroidal antiinflammatory drug. DICP. 1990;24(11):1098–104.

    PubMed  CAS  Google Scholar 

  51. Laneuville O, Breuer DK, Dewitt DL, et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271(2):927–34.

    PubMed  CAS  Google Scholar 

  52. Lanier BG, Turner Jr RA, Collins RL, et al. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Am J Med. 1987;83(4B):40–3.

    Article  PubMed  CAS  Google Scholar 

  53. Appelrouth DJ, Baim S, Chang RW, et al. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults. Am J Med. 1987;83(4B):78–81.

    Article  PubMed  CAS  Google Scholar 

  54. Krug H, Broadwell LK, Berry M, et al. Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis. Clin Ther. 2000;22(1):40–52.

    Article  PubMed  CAS  Google Scholar 

  55. Katz JA. NSAIDs and COX-2-selective inhibitors. In: Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM, editors. Essentials of pain medicine and regional anesthesia. 2nd ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 141–58.

    Chapter  Google Scholar 

  56. Patoia L, Santucci L, Furno P, et al. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers. Br J Rheumatol. 1996;35 Suppl 1:61–7.

    Article  PubMed  CAS  Google Scholar 

  57. Buvanendran A, Kroin JS, Tuman KJ, et al. Cerebrospinal fluid and plasma pharmacokinetics of the cyclooxygenase 2 inhibitor rofecoxib in humans: single and multiple oral drug administration. Anesth Analg. 2005;100(5):1320–4, table of contents.

    Article  PubMed  CAS  Google Scholar 

  58. Derry S, Barden J, McQuay HJ, et al. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2008;4:CD004233.

    PubMed  Google Scholar 

  59. Singh G, Fort JG, Goldstein JL, et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study. Am J Med. 2006;119(3):255–66.

    Article  PubMed  CAS  Google Scholar 

  60. Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;1:CD004257.

    PubMed  Google Scholar 

  61. Takemoto JK, Reynolds JK, Remsberg CM, et al. Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. Clin Pharmacokinet. 2008;47(11):703–20.

    Article  PubMed  CAS  Google Scholar 

  62. Croom KF, Siddiqui MA. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. Drugs. 2009;69(11):1513–32.

    Article  PubMed  CAS  Google Scholar 

  63. Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther. 2001;296(2):558–66.

    PubMed  CAS  Google Scholar 

  64. Strassels SA, McNicol E, Suleman R. Postoperative pain management: a practical review, part 1. Am J Health Syst Pharm. 2005;62(18):1904–16.

    Article  PubMed  Google Scholar 

  65. Burke Anne SE, FitzGerald Garret A. Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy of gout. 11th ed. New York: The McGraw-Hill Companies, Inc.; 2006.

    Google Scholar 

  66. White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005;101(5 Suppl):S5–22.

    Article  PubMed  Google Scholar 

  67. Flouvat B, Leneveu A, Fitoussi S, et al. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int J Clin Pharmacol Ther. 2004;42(1):50–7.

    PubMed  CAS  Google Scholar 

  68. Delbos A, Boccard E. The morphine-sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage. 1995;10(4):279–86.

    Article  PubMed  CAS  Google Scholar 

  69. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102(4):822–31.

    Article  PubMed  CAS  Google Scholar 

  70. Cattabriga I, Pacini D, Lamazza G, et al. Intravenous paracetamol as adjunctive treatment for postoperative pain after cardiac surgery: a double blind randomized controlled trial. Eur J Cardiothorac Surg. 2007;32(3):527–31.

    Article  PubMed  Google Scholar 

  71. Laffi G, La Villa G, Pinzani M, et al. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol. 1997;17(6):530–48.

    PubMed  CAS  Google Scholar 

  72. Clark DW, Ghose K. Neuropsychiatric reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). The New Zealand experience. Drug Saf. 1992;7(6):460–5.

    Article  PubMed  CAS  Google Scholar 

  73. Garcia Rodriguez LA. Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis. Semin Arthritis Rheum. 1997;26(6 Suppl 1):16–20.

    Article  PubMed  CAS  Google Scholar 

  74. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol Suppl. 1991;28:6–10.

    PubMed  CAS  Google Scholar 

  75. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology. 1997;112(3):1000–16.

    Article  PubMed  CAS  Google Scholar 

  76. Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med. 1991;91(3):213–22.

    Article  PubMed  CAS  Google Scholar 

  77. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Ann Intern Med. 1990;112(8):559–60.

    PubMed  CAS  Google Scholar 

  78. Corwin HL, Bonventre JV. Renal insufficiency associated with nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 1984;4(2):147–52.

    PubMed  CAS  Google Scholar 

  79. Nies AS. Renal effects of nonsteroidal anti-inflammatory drugs. Agents Actions Suppl. 1988;24:95–106.

    Article  PubMed  CAS  Google Scholar 

  80. Vonkeman HE, van de Laar MA. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010;39(4):294–312.

    Article  PubMed  CAS  Google Scholar 

  81. Taber SS, Mueller BA. Drug-associated renal dysfunction. Crit Care Clin. 2006;22(2):357–74, viii.

    Article  PubMed  CAS  Google Scholar 

  82. Garcia Rodriguez LA, Perez Gutthann S, Walker AM, et al. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ. 1992;305(6858):865–8.

    Article  PubMed  CAS  Google Scholar 

  83. Rabinovitz M, Van Thiel DH. Hepatotoxicity of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 1992;87(12):1696–704.

    PubMed  CAS  Google Scholar 

  84. Stewart DM, Dillman RO, Kim HS, et al. Acetaminophen overdose: a growing health care hazard. Clin Toxicol. 1979;14(5):507–13.

    Article  PubMed  CAS  Google Scholar 

  85. Chun LJ, Tong MJ, Busuttil RW, et al. Acetaminophen ­hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43(4):342–9.

    Article  PubMed  CAS  Google Scholar 

  86. Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med. 1997;42:453–83.

    PubMed  CAS  Google Scholar 

  87. Dargan PI, Jones AL. Acetaminophen poisoning: an update for the intensivist. Crit Care. 2002;6(2):108–10.

    Article  PubMed  Google Scholar 

  88. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007;11(3):525–48, vi.

    Article  PubMed  Google Scholar 

  89. Amezcua JL, O’Grady J, Salmon JA, et al. Prolonged paradoxical effect of aspirin on platelet behaviour and bleeding time in man. Thromb Res. 1979;16(1–2):69–79.

    Article  PubMed  CAS  Google Scholar 

  90. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296(13):1633–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Rush Medical College, Chicago, IL, USA

    Asokumar Buvanendran M.D.

  2. Orthopedic Anesthesia, Rush University Medical Center, Chicago, IL, USA

    Asokumar Buvanendran M.D.

Authors
  1. Asokumar Buvanendran M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asokumar Buvanendran M.D. .

Editor information

Editors and Affiliations

  1. The Center for Pain Relief, Inc., West Virginia University, 400 Court Street, Suite 100, Charleston, 25301, West Virginia, USA

    Timothy R. Deer

  2. Stanford Pain Management Center, Redwood City, CA, Clinic Chief, Stanford University School of Medicine, Stanford, 94065, California, USA

    Michael S. Leong

  3. Department of Anesthesiology, Rush Medical College, Professor, Rush University Medical Center, Chicago, 60612, Illinois, USA

    Asokumar Buvanendran

  4. Pennsylvania State University, College of Medicine, Department of Anesthesiology, Milton S. Hershey Medical Center, Hershey, 17033-0850, Pennsylvania, USA

    Vitaly Gordin

  5. Center for Interventional Pain and Spine, Newark, DE USA, Medical Director, Bryn Mawr Hospital, Bryn Mawr, 19010, Pennsylvania, USA

    Philip S. Kim

  6. President, National Institute of Pain, Tampa, 33558, Florida, USA

    Sunil J. Panchal

  7. The LITE Center, Clinical Associate Professor, Medical Director, School of Medicine, Miami, 33143, Florida, USA

    Albert L. Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2013 American Academy of Pain Medicine

About this chapter

Cite this chapter

Buvanendran, A. (2013). Nonsteroidal Anti-inflammatory Drugs. In: Deer, T., et al. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1560-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1560-2_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1559-6

  • Online ISBN: 978-1-4614-1560-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation